CRMD - CorMedix Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$16.00
LOW:
$13.00
MEDIAN:
$13.50
CONSENSUS:
$14.00
UPSIDE:
75.44%
About CorMedix Inc. (https://www.cormedix.com)
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Joseph Todisco | CEO & Chairman of the Board of Directors | 1976 | $1,608,676 USD |
| Kaufman Beth Zelnick | EVP, Chief Legal and Compliance Officer & Corporate Secretary | 1961 | $981,592 USD |
| Elizabeth Hurlburt | Executive Vice President, Chief Operating Officer & Chief Integration Officer | 1979 | $959,370 USD |
| Matthew T. David | EVP & Chief Business Officer | 1978 | $634,855 USD |
| Susan Blum | Executive Vice President & Chief Financial Officer | 1973 | $634,855 USD |
| Michael Seckler | Executive Vice President & Chief Commercial Officer | 1966 | $561,571 USD |
| Beth Steinbrenner | SVP & Chief Human Resource Officer | – | – |
| Donna Ucci | Senior Vice President & Head of Global Quality | – | – |
| Jared L. Crandon | Executive Director of Clinical Portfolio Management | – | – |
| Peter Sullivan BCOP | Senior Vice President of Market Access | – | – |
| Tushar Mukherjee | Senior Vice President & Head of Technical Operations | – | – |